Placentation is a key and tightly regulated process that ensures the normal development of
the placenta and fetal growth. Preeclampsia (PE) is a hypertensive pregnancy-related …

Osteoporosis, a metabolic bone disease characterized by low bone mineral density and
deterioration of bone microarchitecture, has led to a high risk of fatal osteoporotic fractures …

Osteoporosis (OP) and Dermatoporosis (DP) are expressions of the aging process at the
skin and bone levels, respectively. Both conditions are associated with increased morbidity …

Osteoporosis is a widespread systemic disease characterized by a decrease in bone mass
and an imbalance of the microarchitecture of bone tissue. Experimental and clinical studies …

Osteoporosis is an age-related disorder characterized by progressive bone loss and
impaired bone regeneration following surgery. The key to the treatment of osteoporosis is …

Osteoporosis (OP) is typically brought on by disruption of bone homeostasis. Excessive
oxidative stress and mitochondrial dysfunction are believed to be the primary mechanisms …

A metabolic bone disorder called osteoporosis is characterized by decreased bone mass
and compromised microarchitecture. This condition can deteriorate bones and raise the risk …

Osteoporosis is a common metabolic disease in middle-aged and elderly people. It is
characterized by a reduction in bone mass, compromised bone microstructure, heightened …

With the discovery of the intrinsic enzyme‐like activity of metal oxides, nanozymes garner
significant attention due to their superior characteristics, such as low cost, high stability, multi …

Bone defects caused by trauma, tumor resection, and infections are significant clinical
challenges. Excessive reactive oxygen species (ROS) usually accumulate in the defect area …